Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Fate Therapeutics Inc
About FATE
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to bringing off-the-shelf, multiplexed-engineered, induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. The Company's pipeline includes iPSC-derived, chimeric antigen receptor (CAR)-targeted T-cell and NK cell product candidates. The iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. The Company's product candidates under development include FT819, FT522, FT825, FT836, and others. FT819 is its first iPSC-derived CAR T-cell product candidate. FT825 is its first iPSC-derived CAR T-cell product candidate for the treatment of solid tumors being developed in collaboration with Ono Pharmaceutical. FT836 is the Company's multiplexed-engineered CAR T-cell product candidate targeting MHC proteins MICA and MICB.
Find out what a historical investment in Fate Therapeutics Inc would be worth today using our FATE stock calculator.
Market Capitalisation
$229.62M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.7M
High today
$2.16
Low today
$1.93
Open price
$2.00
52-week high
$2.88
52-week low
$0.91
Ready to start your investing journey with Stake?
Open an accountHow do I buy FATE shares in Australia?
Buying FATE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Fate Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FATE
What is the ticker symbol of Fate Therapeutics Inc?
The ticker symbol for Fate Therapeutics Inc is FATE.
How much is one share of FATE?
One share of FATE is valued at $2.07 as of 13 June 2026.
What is the market capitalisation of Fate Therapeutics Inc FATE?
As of 13 June 2026 Fate Therapeutics Inc has a market cap of $229.62M.
What is the 52-week high for Fate Therapeutics Inc stock?
The Fate Therapeutics Inc 52-week high stock price is $2.88.
What is the 52-week low for Fate Therapeutics Inc stock?
The Fate Therapeutics Inc 52-week low stock price is $0.91.
Can I buy FATE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FATE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FATE on Stake
- Buy FATE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FATE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FATE related stocks